Episodes
Friday Sep 22, 2023
Friday Sep 22, 2023
More than 46 million people in the US met diagnostic criteria for a substance use disorder (SUD) in 2021. These numbers are staggering and suggest that SUD is more common than diabetes in the United States. However, only 6% received treatment. Expanding the care delivery model is essential to improving treatment access and enhancing physical, mental, and social/societal outcomes. Pharmacists can play a key role.
Guest Authors: Melissa C. Palmer, PharmD, BCPS, BCPP and Amanda Stahnke, PharmD, BCACP
Music by Good Talk
Wednesday Jun 08, 2022
The Top Ten Things Every Clinician Should Know About Sacubitril/Valsartan
Wednesday Jun 08, 2022
Wednesday Jun 08, 2022
Sacubitril/valsartan is considered part of the backbone of guideline-recommended therapies for the management of patients with heart failure. In 2021, sacubitril/valsartan became the preferred treatment over an ACEi or ARB in patients with heart failure with reduced ejection fraction (HFrEF) because it reduces the risk of cardiovascular death and hospitalization for heart failure in nearly all adult patients with chronic heart failure. All clinicians should be familiar with the indications, dosing, safety, and monitoring of sacubitril/valsartan. Affordability, access, and inappropriate dose titration remain major barriers to achieving optimal outcomes.
Guest Authors: Jessica Wooster, PharmD, BCACP and Elizabeth Yett, PharmD, BCACP
Special Guest: Dustin (DJ) Clark, PharmD, BCACP
Music by: Good Talk
Friday Jul 30, 2021
Friday Jul 30, 2021
Allergic rhinitis affects millions of children and adults. Indeed, it is the fifth most common chronic disease in the United States. Although people do not die from allergic rhinitis, it sure can make you feel miserable, disturb sleep, and impair daily activities. Guidelines recommend the use of intranasal corticosteroids on a daily basis since the onset of action takes a few days. In reality, however, patients adjust their treatment according to the severity of their symptoms. As-needed corticosteroid use is effective for the treatment and prevention of asthma symptoms. Can we apply this same concept to allergic rhinitis? Could the as-needed use of intranasal corticosteroids achieve the same outcomes as daily use?
Guest Authors: Lalitha Sukumar, PharmD; Alyssa Gallipani, PharmD, BCACP; and Rahul Jacob, PharmD
Music by Good Talk
Friday Nov 13, 2020
Using shared decision-making tools: Are they worth it?
Friday Nov 13, 2020
Friday Nov 13, 2020
There’s no denying that shared decision making (SDM) is an effective communication approach for making patient-centered medical decisions across a variety of health conditions. However, while tools for SDM are often useful during patient visits with practitioners, studies have yielded mixed results with regard to patient outcomes. A new study explores the impact of a SDM tool for anticoagulation selection in patients with atrial fibrillation compared to standard care.
Guest Authors: Ashley Meredith, PharmD, BCACP, BCPS, CDCES and Chandler Howell, PharmD
Music by Good Talk
Friday Aug 16, 2019
The Power of Pharmacist-to-Pharmacist Handoffs During Transitions of Care
Friday Aug 16, 2019
Friday Aug 16, 2019
Hospital readmissions are often medication-related and potentially preventable. Pharmacists can play a vital role in improving medication outcomes during transitions of care (TOC). Although numerous TOC practice models have been described, it remains unclear what practices will promote optimal continuity of care. A recently published study in the Journal of the American Pharmacists Association (JAPhA) examined the impact of pharmacist-to-pharmacist handoffs using electronic communications to reduce hospital readmissions in high-risk patients.
Guest Authors: Jessica Wooster, PharmD, BCACP and Laressa Bethishou, PharmD, BCPS
Music by Good Talk
Monday Jun 10, 2019
If Your Heart’s Not into It, Do You Really Need to Take Your Meds?
Monday Jun 10, 2019
Monday Jun 10, 2019
Dilated cardiomyopathy is the leading cause of sudden cardiac death and heart failure (HF) and the chief indication for cardiac transplantation. However, approximately 40% of patients see a significant improvement in left ventricular ejection fraction and reduction in the left ventricle size over time with pharmacologic treatment. As deprescribing becomes an increasingly important part of our clinical practice, we need more data about how deprescribing impacts outcomes, particularly in chronic diseases such as heart failure. The recently published TRED-HF is attempted to address this important question: Is the burden of lifelong therapy with medications necessary or worth it in patients with "recovered" dilated cardiomyopathy?
Guest Author: Jennifer Pruskowski, PharmD, BCPS, BCGP, CPE
Music by Good Talk
Saturday Apr 13, 2019
D-PRESCRIBE Study: As Age Goes Up, The Medication Must Go Down!
Saturday Apr 13, 2019
Saturday Apr 13, 2019
The D-PRESCRIBE study provides compelling evidence that a focused, systematic medication review conducted by community-based pharmacists coupled with patient education and written recommendations to prescribers results in a significant reduction in the use of potentially inappropriate medications. In this episode, Christine Dimaculangan reviews the methods and results of the D-PRESCRIBE study and our expert panelists discuss its implications and implementation.
Guests: Christine Dimaculangan, PharmD.; Nicole Brandt, PharmD, MBA, BCPP, BCGP; and Emily Prohaska, PharmD, BCACP, BCGP
Music by Good Talk